Emerging evidence also points to the tumor-draining lymph node microenvironment, including PD-L1–positive dendritic cells and exhausted PD-1–positive CD8+ T cells, as contributors to recurrence and nodal spread, suggesting that the prognostic utility may extend beyond the primary tumor [217,222]. The gene discussed is PDCD1; the disease is neoplasm.